NASDAQ:DVAX - Dynavax Technologies News Headlines

$3.99
+0.08 (+2.05 %)
(As of 08/18/2019 04:00 PM ET)
Today's Range
$3.86
Now: $3.99
$4.08
50-Day Range
$2.69
MA: $3.49
$4.37
52-Week Range
$2.60
Now: $3.99
$14.35
Volume1.31 million shs
Average Volume2.06 million shs
Market Capitalization$259.95 million
P/E RatioN/A
Dividend YieldN/A
Beta0.63

Headlines

Dynavax Technologies (NASDAQ DVAX) News Headlines

Source:
DateHeadline
Dynavax Technologies (DVAX) Buy Rating Reaffirmed at William BlairDynavax Technologies' (DVAX) Buy Rating Reaffirmed at William Blair
www.americanbankingnews.com - August 16 at 5:27 PM
Dynavax Announces Andrew Hack, M.D., Ph.D., Has Joined Board of DirectorsDynavax Announces Andrew Hack, M.D., Ph.D., Has Joined Board of Directors
finance.yahoo.com - August 13 at 5:07 AM
Dynavax Technologies Co. (NASDAQ:DVAX) Director Purchases $50,001.00 in StockDynavax Technologies Co. (NASDAQ:DVAX) Director Purchases $50,001.00 in Stock
www.americanbankingnews.com - August 12 at 8:59 PM
Dynavax Technologies Corp (DVAX) Q2 2019 Earnings Call TranscriptDynavax Technologies Corp (DVAX) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 9 at 5:12 AM
Dynavax prices equity offering; shares down 5% premarketDynavax prices equity offering; shares down 5% premarket
seekingalpha.com - August 8 at 9:58 AM
Edited Transcript of DVAX earnings conference call or presentation 7-Aug-19 8:30pm GMTEdited Transcript of DVAX earnings conference call or presentation 7-Aug-19 8:30pm GMT
finance.yahoo.com - August 8 at 9:58 AM
Dynavax Technologies Announces Pricing of $70.1 Million Public Offering of Common Stock, Non Voting Preferred Stock and Warrants to Purchase Common StockDynavax Technologies Announces Pricing of $70.1 Million Public Offering of Common Stock, Non Voting Preferred Stock and Warrants to Purchase Common Stock
finance.yahoo.com - August 8 at 9:58 AM
Dynavax Technologies Corporation (DVAX) Q2 2019 Results - Earnings Call TranscriptDynavax Technologies Corporation (DVAX) Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 7 at 10:52 PM
Dynavax Technologies (DVAX) Reports Q2 Loss, Tops Revenue EstimatesDynavax Technologies (DVAX) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - August 7 at 10:52 PM
Dynavax readies equity offering; shares off 18% after hoursDynavax readies equity offering; shares off 18% after hours
seekingalpha.com - August 7 at 5:50 PM
Dynavax Announces Second Quarter 2019 Financial ResultsDynavax Announces Second Quarter 2019 Financial Results
finance.yahoo.com - August 7 at 5:50 PM
Dynavax Technologies Announces Proposed Public Offering of Common Stock, Non-Voting Preferred Stock and Warrants to Purchase Common StockDynavax Technologies Announces Proposed Public Offering of Common Stock, Non-Voting Preferred Stock and Warrants to Purchase Common Stock
finance.yahoo.com - August 7 at 5:50 PM
Dynavax Technologies (DVAX) to Release Earnings on WednesdayDynavax Technologies (DVAX) to Release Earnings on Wednesday
www.americanbankingnews.com - July 31 at 9:21 AM
Dynavax Technologies Co. (NASDAQ:DVAX) Receives Consensus Recommendation of "Hold" from BrokeragesDynavax Technologies Co. (NASDAQ:DVAX) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - July 26 at 2:35 AM
Dynavax Technologies to Report Second Quarter 2019 Financial Results and Host Conference Call on August 7Dynavax Technologies to Report Second Quarter 2019 Financial Results and Host Conference Call on August 7
finance.yahoo.com - July 25 at 12:32 AM
Are These 2 Beaten-Down Biotech Stocks Worth Buying?Are These 2 Beaten-Down Biotech Stocks Worth Buying?
finance.yahoo.com - July 23 at 11:45 AM
Here's Why Dynavax Technologies Fell Again TodayHere's Why Dynavax Technologies Fell Again Today
finance.yahoo.com - July 22 at 5:29 PM
Dynavax Technologies Sees Hammer Chart Pattern: Time to Buy?Dynavax Technologies Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - July 19 at 11:01 AM
Dynavax: Last Chance to Make GoodDynavax: Last Chance to Make Good
finance.yahoo.com - July 11 at 5:42 PM
Why Dynavax Technologies' Stock Tanked in JuneWhy Dynavax Technologies' Stock Tanked in June
finance.yahoo.com - July 4 at 5:40 PM
Why Dynavax Technologies Stock Tanked in JuneWhy Dynavax Technologies' Stock Tanked in June
www.fool.com - July 4 at 12:34 PM
Here’s What Hedge Funds Think About Dynavax Technologies Corporation (DVAX)Here’s What Hedge Funds Think About Dynavax Technologies Corporation (DVAX)
finance.yahoo.com - June 27 at 5:35 PM
Dynavax: Still Holding My Worst InvestmentDynavax: Still Holding My Worst Investment
seekingalpha.com - June 20 at 5:40 PM
Dynavax Technologies Corporation (DVAX) Presents At 2019 ASCO Annual Meeting - SlideshowDynavax Technologies Corporation (DVAX) Presents At 2019 ASCO Annual Meeting - Slideshow
seekingalpha.com - June 4 at 5:03 PM
Dynavax to Present at the William Blair & Co. Annual Growth Stock ConferenceDynavax to Present at the William Blair & Co. Annual Growth Stock Conference
www.nasdaq.com - June 3 at 4:58 PM
Overall Response Rate of 76% in Advanced Melanoma Patients with Dynavax’s SD-101 in Combination with KEYTRUDA® (pembrolizumab); Data Presented Today at the 2019 ASCO Annual MeetingOverall Response Rate of 76% in Advanced Melanoma Patients with Dynavax’s SD-101 in Combination with KEYTRUDA® (pembrolizumab); Data Presented Today at the 2019 ASCO Annual Meeting
finance.yahoo.com - June 3 at 4:58 PM
Dynavax to Present at the William Blair & Co. Annual Growth Stock Conference  Dynavax to Present at the William Blair & Co. Annual Growth Stock Conference  
finance.yahoo.com - June 3 at 4:58 PM
Dynavax Presents Phase 2 Data on SD-101 in Combination with KEYTRUDA® (pembrolizumab) for PatientsDynavax Presents Phase 2 Data on SD-101 in Combination with KEYTRUDA® (pembrolizumab) for Patients
www.nasdaq.com - June 1 at 4:44 PM
Dynavax Presents Phase 2 Data on SD-101 in Combination with KEYTRUDA® (pembrolizumab) for Patients with Head and Neck Squamous Cell Carcinoma at the 2019 ASCO Annual MeetingDynavax Presents Phase 2 Data on SD-101 in Combination with KEYTRUDA® (pembrolizumab) for Patients with Head and Neck Squamous Cell Carcinoma at the 2019 ASCO Annual Meeting
finance.yahoo.com - June 1 at 4:44 PM
Dynavax: Circling The WagonsDynavax: Circling The Wagons
seekingalpha.com - May 28 at 4:59 PM
Heres Why Dynavax Technologies Is TumblingHere's Why Dynavax Technologies Is Tumbling
finance.yahoo.com - May 25 at 10:34 AM
Here's Why Dynavax Technologies Is TumblingHere's Why Dynavax Technologies Is Tumbling
finance.yahoo.com - May 25 at 10:34 AM
Dynavax Announces Strategic Restructuring to Focus on its Vaccine BusinessDynavax Announces Strategic Restructuring to Focus on its Vaccine Business
finance.yahoo.com - May 23 at 5:31 PM
Dynavax announces layoffs, CEO retirementDynavax announces layoffs, CEO retirement
finance.yahoo.com - May 23 at 5:31 PM
Could The Dynavax Technologies Corporation (NASDAQ:DVAX) Ownership Structure Tell Us Something Useful?Could The Dynavax Technologies Corporation (NASDAQ:DVAX) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - May 21 at 4:56 PM
Hopeful Signs for These 2 Small Biotech StocksHopeful Signs for These 2 Small Biotech Stocks
finance.yahoo.com - May 10 at 10:23 AM
Is Dynavax Technologies Corporation (DVAX) A Good Stock To Buy?Is Dynavax Technologies Corporation (DVAX) A Good Stock To Buy?
finance.yahoo.com - May 9 at 5:26 PM
Why Dynavax Technologies Stock Is Soaring TodayWhy Dynavax Technologies Stock Is Soaring Today
finance.yahoo.com - May 9 at 5:26 PM
Dynavax Technologies Corp (DVAX) CEO Eddie Gray on Q1 2019 Results - Earnings Call TranscriptDynavax Technologies Corp (DVAX) CEO Eddie Gray on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 10:39 AM
Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue EstimatesDynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - May 9 at 10:39 AM
Edited Transcript of DVAX earnings conference call or presentation 8-May-19 8:30pm GMTEdited Transcript of DVAX earnings conference call or presentation 8-May-19 8:30pm GMT
finance.yahoo.com - May 9 at 10:39 AM
Dynavax Technologies Corp (DVAX) Q1 2019 Earnings Call TranscriptDynavax Technologies Corp (DVAX) Q1 2019 Earnings Call Transcript
www.fool.com - May 9 at 12:13 AM
Dynavax Announces First Quarter 2019 Financial ResultsDynavax Announces First Quarter 2019 Financial Results
www.marketwatch.com - May 8 at 5:08 PM
Dynavax Technologies Corp. to Host Earnings CallDynavax Technologies Corp. to Host Earnings Call
finance.yahoo.com - May 8 at 5:08 PM
Dynavax Announces First Patient Enrolled in Study of HEPLISAV-B®  in Adults With End-Stage Renal DiseaseDynavax Announces First Patient Enrolled in Study of HEPLISAV-B® in Adults With End-Stage Renal Disease
finance.yahoo.com - May 2 at 5:14 PM
Analysts Estimate Dynavax Technologies (DVAX) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Dynavax Technologies (DVAX) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - May 1 at 5:11 PM
Dynavax Technologies to Report First Quarter 2019 Financial Results and Host Conference Call on May 8Dynavax Technologies to Report First Quarter 2019 Financial Results and Host Conference Call on May 8
finance.yahoo.com - April 25 at 5:14 PM
Dynavax to Present Data on Toll-like Receptor 9 Agonist SD-101 at the ASCO Annual Meeting 2019Dynavax to Present Data on Toll-like Receptor 9 Agonist SD-101 at the ASCO Annual Meeting 2019
finance.yahoo.com - April 18 at 5:04 PM
Investors Who Bought Dynavax Technologies (NASDAQ:DVAX) Shares Three Years Ago Are Now Down 66%Investors Who Bought Dynavax Technologies (NASDAQ:DVAX) Shares Three Years Ago Are Now Down 66%
finance.yahoo.com - April 6 at 4:41 PM
Dynavax Presents Phase 1b Data on Inhaled DV281 TLR9 Agonist at the 2019 AACR Annual MeetingDynavax Presents Phase 1b Data on Inhaled DV281 TLR9 Agonist at the 2019 AACR Annual Meeting
finance.yahoo.com - April 2 at 1:39 PM
This page was last updated on 8/18/2019 by MarketBeat.com Staff

Featured Article: Equity Income

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel